• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSL0500005 重组人血清白蛋白-干扰素α2b融合蛋白注射液 Injection Biological Products(1) New Drug Application 2005-02-22 杭州九源基因工程有限公司 Hangzhou Jiuyuan Gene Engineering Co Ltd Certificate Issued 2005-12-31 view
CXSB0600055 重组人血清白蛋白-干扰素α2b融合蛋白注射液 Injection Biological Products Supplementary Application 2006-10-10 杭州九源基因工程有限公司 Hangzhou Jiuyuan Gene Engineering Co Ltd Certificate Issued 2007-09-10 view
CXSB0600053 重组人血清白蛋白-干扰素α2b融合蛋白注射液 Injection Biological Products Supplementary Application 2006-10-10 杭州九源基因工程有限公司 Hangzhou Jiuyuan Gene Engineering Co Ltd Certificate Issued 2008-01-03 view
CXSB0600054 重组人血清白蛋白-干扰素α2b融合蛋白注射液 Injection Biological Products Supplementary Application 2006-10-18 杭州九源基因工程有限公司 Hangzhou Jiuyuan Gene Engineering Co Ltd Certificate Issued 2008-01-03 view
CXSB1200008 重组人血清白蛋白-干扰素α2b融合蛋白注射液 Injection Biological Products Supplementary Application 2012-06-19 杭州九源基因工程有限公司 Hangzhou Jiuyuan Gene Engineering Co Ltd Certificate Issued 2014-03-04 view
CXSB1200007 重组人血清白蛋白-干扰素α2b融合蛋白注射液 Injection Biological Products Supplementary Application 2012-06-19 杭州九源基因工程有限公司 Hangzhou Jiuyuan Gene Engineering Co Ltd Certificate Issued 2014-03-04 view
CXSB1200009 重组人血清白蛋白-干扰素α2b融合蛋白注射液 Injection Biological Products Supplementary Application 2012-06-19 杭州九源基因工程有限公司 Hangzhou Jiuyuan Gene Engineering Co Ltd Certificate Issued 2014-03-04 view